Enzymotec Ltd. Sustainability Profile
Enzymotec Ltd., a leading biotechnology company headquartered in Israel, has been at the forefront of the nutritional and pharmaceutical industries since its founding in 1998. With a strong presence in North America, Europe, and Asia, Enzymotec focuses on developing innovative lipid-based products that cater to the needs of health-conscious consumers and medical professionals alike. The company is renowned for its unique offerings, including advanced lipid formulations and nutritional supplements that support cognitive health and overall wellness. Enzymotec's commitment to research and development has positioned it as a key player in the market, with notable achievements in product efficacy and safety. As a pioneer in the field, Enzymotec continues to drive advancements in nutritional science, making significant contributions to both consumer health and the broader industry landscape.
DitchCarbon Score
How does Enzymotec Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Enzymotec Ltd.'s score of 93 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Enzymotec Ltd., headquartered in Israel (IL), currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of International Flavors & Fragrances Inc. (IFF), which cascades its climate commitments and initiatives down to Enzymotec. As part of its corporate family relationship with IFF, Enzymotec adheres to various sustainability initiatives, including those related to the Science Based Targets initiative (SBTi), CDP, and RE100. However, specific reduction targets or achievements for Enzymotec are not detailed in the available data. The absence of direct emissions data suggests that Enzymotec is still in the process of establishing its own climate commitments or may rely on the broader sustainability framework set by IFF. This context highlights the importance of corporate responsibility in addressing climate change within the industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 135,417,000 | 00,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 141,042,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Enzymotec Ltd.'s Industry?
How Carbon Intensive is Enzymotec Ltd.'s Location?
Enzymotec Ltd.'s Scope 3 Categories Breakdown
Enzymotec Ltd.'s Scope 3 emissions, which decreased by 7% last year and increased by approximately 458% since 2014, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 78% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Enzymotec Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Enzymotec Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
